ClinChoice

ClinChoice is a mid-size, global CRO with over 30 years of experience, specializing in end-to-end clinical trial services across major therapeutic areas including oncology, inflammation & immunology, cardiometabolic, and central nervous system disorders. The company leverages a team of over 3,000 experts to deliver seamless support globally, having managed more than 3,000 studies since 2010 and supported over 10,000 regulatory submissions. Its business model is heavily focused on serving the biotech sector, with more than 60% of its clients being emerging and mid-size biotech companies, while also maintaining partnerships with 6 of the top 10 global pharma firms.

Integrated global CRO service platform encompassing clinical operations, data management, biometrics, regulatory affairs, and therapeutic expertise. Utilizes clinical trial management systems, electronic data capture, and specialized methodologies for complex trials in areas like oncology and CNS.

Operates in the highly competitive global CRO market, competing against large public players (e.g., IQVIA, ICON) with greater scale and numerous smaller niche firms. ClinChoice differentiates through its mid-size, full-service model offering personalized engagement, deep therapeutic expertise, and a strong focus on biotech clients.